Cannabis


Ullman Discusses FDA Revision of Consumer Info on CBD
November 27, 2019 | Cannabis | Health Services

Marc Ullman is quoted in a Nutraingredients-USA article, “FDA revises consumer info on CBD, says ingredient is not GRAS, sends 15 CBD warning letters.”

Click here to read the article.

Read More
Ullman Speaker at Dietary Supplement Regulatory Strategy Conference
November 20, 2019 | Cannabis | Health Services | Compliance Investigations & White Collar

On December 4-5, Marc Ullman will be speaking at the 4th Annual Dietary Supplement Regulatory Strategy Conference at the Key Bridge Marriott in Arlington, VA.

Topics to be addressed include:

  • Ongoing Impact of CBD Use in the Dietary Supplement Industry
  • Regulatory Oversight of Social Media Influencers & Supplement Claims
  • Interpretation of USDA National Bioengineered
Read More
Ullman Quoted in Nutra ingredients-usa.com Article
October 29, 2019 | Cannabis | Health Services | Compliance Investigations & White Collar

Marc Ullman was quoted in a Nutra ingredients-usa.com article, “Mississippi adds to regulatory tangle with warning on CBD products.”

Click here to read article.

Read More
Ullman Speaker at SupplySide West and American Herbal Products Association
October 11, 2019 | Cannabis | Health Services | Compliance Investigations & White Collar

Marc Ullman will be a speaker at SupplySide West summit, “CBD from Seed to Shelf: The Supply Side Story.” Ullman’s session will be “Legal Eagles: Risk Update, Plus Your Questions Answered.” The Session will take place on Oct. 16 at Mandalay Bay, Las Vegas, NV.

Program Description:

Cannabinoids are on everyone’s mind—consumers, industry, regulators and

Read More
Ullman Quoted in NutraIngredients-USA
August 16, 2019 | Health Services | Cannabis

Marc Ullman was quoted in a NutraIngredients-usa.com article, “Patchwork quilt of regulations could further complicate CBD picture if FDA doesn’t act quickly.”

Click here to read the article.

Read More
Ullman Quoted on Confusing Web of CBD Laws
August 13, 2019 | Cannabis | Health Services | Complex Torts & Product Liability

Marc Ullman was quoted in the Long Island Business News’ article, “Confusing Web of Laws Muddles CBD Industry.” The article discusses the confusing web of contradictory laws and inconsistent enforcement in products containing CBD.

The sudden swell in CBD products stems in large part from the passage of the 2018 Farm Bill. CBD is derived

Read More
Ullman Quoted in Natural Products Insider
April 19, 2019 | Cannabis | Health Services | Compliance Investigations & White Collar

Marc Ullman was quoted in a Natural Products Insider article, “The Vitamin Shoppe to carry CBD following FDA’s move to exercise ‘enforcement discretion.'” The article discusses the FDA’s announcement to exercise “enforcement discretion” related to foods and supplements containing CBD as a factor driving mass-market retailer activity in the category, including The Vitamin Shoppe’s recent move

Read More
Ullman and Shapiro Present at Supplyside East
March 8, 2019 | Cannabis | Compliance Investigations & White Collar

On April 10, 2019, Marc Ullman and Steven Shapiro will be featured speakers at Supplyside East, presenting on the topic, “What Is the Regulatory Current State of Play with CBD?”

The pair will discuss the latest insights around regulatory issues related to cannabidiol at the international, national and local levels.

Supplyside East, which bills itself

Read More
Ullman Quoted on Future of CBD Regs upon Gottlieb’s Departure
March 6, 2019 | Cannabis | Compliance Investigations & White Collar

Dr. Scott Gottlieb, who announced his plan to resign as FDA commissioner on March 5, 2019, had in the previous week just announced plans to develop a regulatory framework for CBD.

Marc Ullman spoke with Nutraingredients-USA about what might happen with the CBD initiative for the article entitled “Advocates hopeful that Gottlieb’s departure won’t derail

Read More
Ullman Quoted in NutraIngredients USA
February 28, 2019 | Health Services | Cannabis

Marc Ullman was quoted in a Nutraingredients-USA article, “Gottlieb: FDA plans meeting in April on new CBD regulations.” FDA Commissioner Scott Gottlieb said the agency is planning a public meeting in April to initiate a rule making procedure on CBD.

Click here to read the article.

Read More
Previous PageNext Page

Get legal updates and news delivered to your inbox